This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program
Similar Posts
HTO Nevada, Inc. dba Kirkman – 719074 – 01/27/2026
CGMP/Finished Pharmaceuticals/AdulteratedCybersecurity Vulnerabilities with Certain Patient Monitors from Contec and Epsimed: FDA Safety Communication
The FDA is raising awareness about cybersecurity vulnerabilities with Contec CMS8000 and Epsimed MN-120 patient monitors.Clinical Outcome Assessments (COA) Qualification Program Submissions
Clinical Outcome Assessments (COA) Qualification Program SubmissionsSafety Labeling Changes—Implementation of Section 505(o)(4) of the FD&C Act
This draft guidance provides information on the implementation of the statutory provision that authorizes FDA to require application holders for certain drug and biological products to make labeling changes based on new safety information that becomes available after approval of the drug.Weight Loss Product Notifications
Learn about the warnings for weight loss products that contain hidden drugs and other hidden ingredients.Withdrawn and Expired Guidances | Drugs
Withdrawn and Expired Guidances | Drugs